Product Information
FT LAXATIVE EC 5 MG TABLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0374 per EA under NDC 70677108603. Its NADAC has been published 168 times since Sep 6, 2023.
Strength
5 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677108603
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
11/18/2026
Active Ingredients
BISACODYLApproval Type
OTC MONOGRAPH DRUG
FDA Application
505G(a)(3)On Market Since
4/15/2023
Pharmacological Classes
Price Statistics
The NADAC for FT LAXATIVE EC 5 MG TABLET has been published 168 times since Sep 6, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0374 per EA |
|---|---|
| All-time high | $0.0534 (Feb 14, 2024) |
| All-time low | $0.0350 (Apr 22, 2026) |
| 52-week high | $0.0464 |
| 52-week low | $0.0350 |
| Median price | $0.0392 |
| Average price | $0.0412 |
| Largest weekly change | +34.4% (Jan 17, 2024) |
| Weeks tracked | 168 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bisacodyl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Stimulant Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT LAXATIVE EC 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FT LAXATIVE EC 5 MG TABLET, manufactured by Strategic Sourcing Services LLC, is $0.0374 per EA (NDC 70677108603), effective Nov 18, 2026.
How has the price of FT LAXATIVE EC 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for FT LAXATIVE EC 5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 168 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for FT LAXATIVE EC 5 MG TABLET?
Since Sep 6, 2023, the NADAC for FT LAXATIVE EC 5 MG TABLET has ranged from a low of $0.0350 (Apr 22, 2026) to a high of $0.0534 (Feb 14, 2024), with a median of $0.0392 per EA.
Are there cheaper alternatives to FT LAXATIVE EC 5 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HM LAXATIVE EC 5 MG TABLET, is $0.0372 per EA — about 1% below FT LAXATIVE EC 5 MG TABLET.
Who manufactures FT LAXATIVE EC 5 MG TABLET?
FT LAXATIVE EC 5 MG TABLET (NDC 70677108603) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.